For GHK-Cu, a 50mg vial typically pairs with 2mL to 3mL of diluent depending on whether researchers want a 16.67mg/mL or 25mg/mL stock
The molecule was advanced into clinical development by the Croatian pharmaceutical company Pliva under the designations PL-10, PLD-116, and PL 14736 for inflammatory bowel disease research
Our approach to cellulite treatment, informed by our philosophy of individualized care and effective solutions, aims to tackle these factors comprehensively
It does not, by itself, establish that the dominant component is the intended GHK-Cu complex
Despite this, the peptide is widely available online in injectable and ingestible forms, often sold with labels that say for research use only, in an effort to hide from regulatory action
Consider reduced dosing and careful monitoring of response